US Stock Market Closed

Dashboard

Baudax Bio, Inc. (BXRX)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity
Analyst Opinion

H

Leverage & Liquidity

H

Fundamental Variables

Rating Performance

FV Performance

About

Baudax Bio, Inc. is a pharmaceutical company focusing on developing and commercializing products for acute care settings. The company was founded in 2015 and is headquartered in Malvern, PA.

CEO

Gerri A. Henwood

Employees

25

Industry

-

Sector

-

Headquarters

Malvern

Exchange

NASDAQ

Summary Stats

Market Cap

5.06M

Revenue

-

Net Income

-

EPS

$0.00

Price-to-Earnings

-

Price-to-Book

-

Debt-to-Equity

-

News

Analyst Ratings

Price targets projected by 3 analysts

High

$11.00

Average

$9.00

Low

$7.00

Ratings calculated by 3 analysts

Buy

3

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Above by $5.60

Actual

-$15.60 +26.4%

Consensus

-21.2

Report Date

Year Ago

-0.2

Year Ago Change %

Down 7700%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites